Cancer Treatment News and Research

RSS

OIST researchers create taurine-modified photosensitizer for brain cancer therapy

Photodynamic therapy is often used to treat brain tumors because of its specificity—it can target very small regions containing cancerous cells while sparing the normal cells around it from damage. It works by injecting a drug called a photosensitizer into the bloodstream, where it gathers in cells, and then exposing the drug-filled cells to light.

23 Jun 2017

Cells key to blood vessel formation can also produce tumors and enable their spread

While it's widely held that tumors can produce blood vessels to support their growth, scientists now have evidence that cells key to blood vessel formation can also produce tumors and enable their spread.

20 Jun 2017

Scientists develop new three-in-one blood test that could transform prostate cancer treatment

Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes.

19 Jun 2017

Investigation evaluates new drug in microgravity to activate immune system, help combat cancer

On Earth, research into antibody-drug conjugates to treat cancer has been around a while. The research presents a problem, though, because Earth-based laboratories aren't able to mimic the shape of the cancer cell within the body, which can sometimes produce incorrect findings.

15 Jun 2017

Children can reliably self-report outcomes of experimental therapy in clinical trials, study suggests

Children as young as 8 years old with incurable cancer can reliably characterize the impact an experimental therapy has on their symptoms and quality of life - even at the earliest stages of drug development - making self-reported patient outcomes a potential new clinical trial endpoint, according to a longitudinal validity study led by Children's National Health System researchers.

15 Jun 2017

New approach could potentially prevent muscle wasting in muscular dystrophy and cancer

Monash University's Biomedicine Discovery Institute researchers have collaboratively developed a therapeutic approach that dramatically promotes the growth of muscle mass, which could potentially prevent muscle wasting in diseases including muscular dystrophy and cancer.

14 Jun 2017

Researchers find link between chemotherapy during childhood and cognitive problems later in life

Young adults who had chemotherapy as a child have decreased cognitive flexibility and a weaker short-term memory.

14 Jun 2017

Melbourne study offers hope for better lung cancer treatment

A Melbourne study is set to improve treatment options for patients with the second most common type of lung cancer, lung squamous cell carcinoma, a disease for which new anti-cancer drugs are urgently needed.

13 Jun 2017

Magnetic nanoparticle aggregates can induce death of cancer cells

An international team in which a UPM researcher is involved has shown that it is possible to mechanically destroy cancer cells by rotating magnetic nanoparticles attached to them in elongated aggregates.

13 Jun 2017

New cancer drug shows promise to treat leukemia in mouse models

Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults.

9 Jun 2017

Research shows how adipose tissue reduces efficiency of radiotherapy in breast cancer patients

According to research published online in The FASEB Journal, repeated irradiation of breast fat (also known as adipose tissue) produces an inflammatory response that ultimately reduces the efficiency of radiotherapy in breast cancer patients.

8 Jun 2017

Study reveals cancer-fighting power of onions

The next time you walk down the produce aisle of your grocery store, you may want to reach for red onions if you are looking to fight off cancer.

7 Jun 2017

Two-pronged algorithm may prove to be accurate tool for predicting response to checkpoint inhibitors

The class of immunotherapies known as checkpoint inhibitors have proven to be a highly effective and advantageous treatment option for many cancer patients, but they don't work well for everyone, and oncologists have no reliable way to determine in advance which patients are likely to respond to these drugs.

7 Jun 2017

New immunotherapy sends multiple myeloma into remission

Researchers are reporting the impressive results of a new cell and gene therapy that has achieved unprecedented success in treating multiple myeloma patients. Although the study is an early one and the population only included 35 people, every one of the patients responded to the treatment and 33 (94%) were in some degree of clinical remission within two months.

6 Jun 2017

Greater gut bacteria diversity linked to longer progression-free survival in metastatic melanoma patients

The blend of bacteria in the digestive tract of metastatic melanoma patients is associated with disease progression or delay in patients treated with immunotherapy, researchers at The University of Texas MD Anderson Cancer Center report at the 2017 annual meeting of the American Society of Clinical Oncology.

6 Jun 2017

Study: Black and white men with prostate cancer prioritize treatment-related factors differently

When it comes to making decisions about which prostate cancer treatment to choose, black and white men prioritize certain treatment-related factors differently, according to a University of North Carolina Lineberger Comprehensive Cancer Center study.

6 Jun 2017

Psychological intervention reduces fear of recurrence in breast cancer survivors

About 50% of all cancer survivors and 70% of young breast cancer survivors report moderate to high fear of recurrence.

5 Jun 2017

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

Novartis today announced a first-of-its-kind collaboration with IBM Watson Health on an initiative to optimize cancer care and improve patient outcomes.

5 Jun 2017

Online intervention can relieve distress, improve quality of life for cancer patients

Most patients experience significant distress after they are diagnosed with cancer. This distress not only erodes quality of life, but can also negatively affect the course of the disease and the patient's ability to tolerate treatment.

5 Jun 2017

Study finds steady decline in severe health problems for childhood cancer survivors

Treatments for childhood cancer are often intense and carry the risk of lifelong health problems for survivors. An analysis of 23,600 childhood cancer survivors in the Childhood Cancer Survivor Study (CCSS), funded by the National Institutes of Health, found that the rate of severe health problems occurring five or more years after diagnosis has declined over time.

5 Jun 2017

Cancer Treatment News and Research

OIST researchers create taurine-modified photosensitizer for brain cancer therapy

Cells key to blood vessel formation can also produce tumors and enable their spread

Scientists develop new three-in-one blood test that could transform prostate cancer treatment

Investigation evaluates new drug in microgravity to activate immune system, help combat cancer

Children can reliably self-report outcomes of experimental therapy in clinical trials, study suggests

New approach could potentially prevent muscle wasting in muscular dystrophy and cancer

Researchers find link between chemotherapy during childhood and cognitive problems later in life

Melbourne study offers hope for better lung cancer treatment

Magnetic nanoparticle aggregates can induce death of cancer cells

New cancer drug shows promise to treat leukemia in mouse models

Research shows how adipose tissue reduces efficiency of radiotherapy in breast cancer patients

Study reveals cancer-fighting power of onions

Two-pronged algorithm may prove to be accurate tool for predicting response to checkpoint inhibitors

New immunotherapy sends multiple myeloma into remission

Greater gut bacteria diversity linked to longer progression-free survival in metastatic melanoma patients

Study: Black and white men with prostate cancer prioritize treatment-related factors differently

Psychological intervention reduces fear of recurrence in breast cancer survivors

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

Online intervention can relieve distress, improve quality of life for cancer patients

Study finds steady decline in severe health problems for childhood cancer survivors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News